The Patent Finder
AP

Antares Pharma, Inc.

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

79 patents currently held

8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
12 more records may belong here and await a decision; they are not counted.

The next term ends in May 2027. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
18
Ending by 2030
May 2027
Next term end
27
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Nov 28, 2026
  • 1 fee due Dec 27, 2026
    The maintenance fee for Injector Safety Device (US 11,684,723) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
  • 1 fee due Jan 23, 2027
    The maintenance fee for Needle Assisted Jet Injection Device Having Reduced Trigger Force (US 10,357,609) comes due Jan 23, 2027. Unpaid by Jul 23, 2027, it lapses early.
  • 1 fee due Feb 8, 2027
    The maintenance fee for Injection Device Having Variable Dosing (US 11,717,610) comes due Feb 8, 2027. Unpaid by Aug 9, 2027, it lapses early.
  • 1 fee due Mar 29, 2027
    The maintenance fee for Injector with Adjustable Dosing (US 9,144,648) comes due Mar 29, 2027. Unpaid by Sep 29, 2027, it lapses early.
  • 1 fee due Apr 3, 2027
    The maintenance fee for Needle Assisted Jet Injection Administration of Testosterone Compositions (US 11,771,646) comes due Apr 3, 2027. Unpaid by Oct 4, 2027, it lapses early.
  • 3 fees due May 14 to 26, 2027 · next May 14
  • 2 fees due Jun 19 to 26, 2027 · next Jun 19
  • 2 fees due Jul 2 to 23, 2027 · next Jul 2
  • 1 fee due Aug 11, 2027
    The maintenance fee for Hazardous Agent Injection System (US 10,555,954) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
  • 1 fee due Sep 17, 2027
    The maintenance fee for Injection Device (US 10,589,035) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.
  • 1 fee due Oct 7, 2027
    The maintenance fee for Multiple Dosage Injector with Rack and Pinion Dosage System (US 10,610,649) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.
  • 1 fee due Nov 12, 2027
    The maintenance fee for Testosterone Ester Triglyceride Formulations (US 10,646,495) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 3 of the patents on this record were granted since Aug 17, 2026
  • 1 term has ended since Aug 17, 2026

What they patent

The 5 largest of its 27 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 10,688,250Two-Stage Reconstituting Injector
In force
 · High confidence
In forceHigh confidence
US 12,121,704Injector with Adjustable Dosing
In force
 · High confidence
In forceHigh confidence
US 11,547,808Two-Stage Reconstituting Injector
In force
 · Medium confidence
In forceMedium confidence
US 9,144,648Injector with Adjustable Dosing
In force
 · High confidence
In forceHigh confidence
US 10,543,316Injector with Adjustable Dosing
In force
 · High confidence
In forceHigh confidence
US 11,471,600Injector With Adjustable Dosing
In force
 · Medium confidence
In forceMedium confidence
US 8,251,947Two-Stage Reconstituting Injector
In force
 · High confidence
In forceHigh confidence
US 9,867,949Injector Safety Device
In force
 · High confidence
In forceHigh confidence
US 10,709,844Injector Safety Device
In force
 · High confidence
In forceHigh confidence
US 11,684,723Injector Safety Device
In force
 · High confidence
In forceHigh confidence
10 of 79 patents shown.
Pro members see all 79.
Pro members: see all 79 patents
Also on record, not counted in the 79: 8 patents in force now held by others · 31 patents ended · 21 applications pending · 13 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited